Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria

Frank Siebenhaar, Petra Staubach, Martin Metz

    The Journal of Allergy and Clinical Immunology
    |November 13, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Real-World Cross-Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified.

    Clinical and translational allergy·2026
    Same author

    Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

    Journal of hematology & oncology·2026
    Same author

    Psychometric evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) in adults with nonadvanced systemic mastocytosis (NonAdvSM).

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
    Same author

    Patients with or without a clonal mast cell disease undergoing venom immunotherapy differ in their CD8 T memory cell response.

    The Journal of investigative dermatology·2026
    Same author

    Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper.

    Allergy·2026
    Same author

    Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.

    The Journal of allergy and clinical immunology·2026